Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR)

Journal of Cardiovascular Magnetic Resonance

Lilia M. Sierra-Galan¹  Anne Marie Valente²  Chiara Bucciarelli-Ducci³  Ellen Ostenfeld⁴  Hajime Sakuma⁵  James Carr⁶  Purvi Parwani⁷  Monvadi B. Srichai⁸  Juliano Lara Fernandes⁹  Subha V. Raman^1,10  Alessia Pepe^1,11  Luba Frank^1,12  Sophie Mavrogeni^1,13  Vanessa M. Ferreira^1,14  Ntobeko Ntusi^1,15  Karen G. Ordovas^1,16  Lauren A. Baldassarre^1,17  Jeanette Schulz-Menger^1,18 

[1] American British Cowdray Medical Center, Mexico City, Mexico;Boston Children’s Hospital, Brigham and Women’s Hospital, Boston, USA;Bristol Heart Institute, Bristol, UK;Bristol National Institute of Health Research (NIHR) Biomedical , Research Centre, Bristol, UK;University Hospitals Bristol, Bristol, UK;University of Bristol, Bristol, UK;Department of Clinical Sciences Lund, Clinical Physiology, Skåne University Hospital Lund, Lund University, Lund, Sweden;Department of Radiology, Mie University School of Medicine, Mie, Japan;Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA;Division of Cardiology, Department of Medicine, Loma Linda University Health, Loma Linda, CA, USA;Georgetown University School of Medicine, Washington, USA;Jose Michel Kalaf Research Institute, Radiologia Clinica de Campinas, São Paulo, Brazil;Krannert Institute of Cardiology, Indiana University, Indianapolis, USA;Magnetic Resonance Imaging Unit, Fondazione G. Monasterio C.N.R., Pisa, Italy;Medical College of Wisconsin, Wisconsin, USA;Onassis Cardiac Surgery Center, Athens, Greece;Kapodistrian University of Athens, Athens, Greece;Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Division of Cardiovascular Medicine, British Heart Foundation Centre of Research Excellence, Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK;University of Cape Town, Cape Town, South Africa;Groote Schuur Hospital, Cape Town, South Africa;University of Washington, Seattle, USA;Yale University, New Haven, CT, USA;harite Hospital, University of Berlin, Berlin, Germany;HELIOS-Clinics Berlin-Buch, Berlin, Germany;

关键词: Cardiovascular magnetic resonance;    Women;    Cardiovascular disease;    Society for Cardiovascular Magnetic Resonance;    Position statement;   

DOI  :  10.1186/s12968-021-00746-z

来源: Springer

【 摘 要 】

This document is a position statement from the Society for Cardiovascular Magnetic Resonance (SCMR) on recommendations for clinical utilization of cardiovascular magnetic resonance (CMR) in women with cardiovascular disease. The document was prepared by the SCMR Consensus Group on CMR Imaging for Female Patients with Cardiovascular Disease and endorsed by the SCMR Publications Committee and SCMR Executive Committee. The goals of this document are to (1) guide the informed selection of cardiovascular imaging methods, (2) inform clinical decision-making, (3) educate stakeholders on the advantages of CMR in specific clinical scenarios, and (4) empower patients with clinical evidence to participate in their clinical care. The statements of clinical utility presented in the current document pertain to the following clinical scenarios: acute coronary syndrome, stable ischemic heart disease, peripartum cardiomyopathy, cancer therapy-related cardiac dysfunction, aortic syndrome and congenital heart disease in pregnancy, bicuspid aortic valve and aortopathies, systemic rheumatic diseases and collagen vascular disorders, and cardiomyopathy-causing mutations. The authors cite published evidence when available and provide expert consensus otherwise. Most of the evidence available pertains to translational studies involving subjects of both sexes. However, the authors have prioritized review of data obtained from female patients, and direct comparison of CMR between women and men. This position statement does not consider CMR accessibility or availability of local expertise, but instead highlights the optimal utilization of CMR in women with known or suspected cardiovascular disease. Finally, the ultimate goal of this position statement is to improve the health of female patients with cardiovascular disease by providing specific recommendations on the use of CMR.

【 授权许可】

CC BY